Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as running revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-02T16:29:29.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces an update to terminology used for artificial intelligence during a transition to “Super Intelligence.”
    Difference
    0.7%
    Check dated 2026-10-26T16:46:48.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The website footer’s revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T21:49:00.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-13T04:20:58.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The latest record history shows Revision: v3.7.0 as the current version, replacing the previous Revision: v3.6.6. This reflects a site update to the record history page.
    Difference
    0.1%
    Check dated 2026-09-21T22:41:07.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The record history shows a new platform revision entry: v3.6.6 superseding v3.6.5. This indicates a small software update to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-08-31T16:59:54.000Z thumbnail image

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.